1. Home
  2. EOLS vs GCI Comparison

EOLS vs GCI Comparison

Compare EOLS & GCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • GCI
  • Stock Information
  • Founded
  • EOLS 2012
  • GCI 1997
  • Country
  • EOLS United States
  • GCI United States
  • Employees
  • EOLS N/A
  • GCI N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • GCI Newspapers/Magazines
  • Sector
  • EOLS Health Care
  • GCI Consumer Discretionary
  • Exchange
  • EOLS Nasdaq
  • GCI Nasdaq
  • Market Cap
  • EOLS 702.2M
  • GCI 734.1M
  • IPO Year
  • EOLS 2018
  • GCI N/A
  • Fundamental
  • Price
  • EOLS $10.51
  • GCI $4.97
  • Analyst Decision
  • EOLS Strong Buy
  • GCI Buy
  • Analyst Count
  • EOLS 6
  • GCI 2
  • Target Price
  • EOLS $22.60
  • GCI $5.55
  • AVG Volume (30 Days)
  • EOLS 695.8K
  • GCI 933.7K
  • Earning Date
  • EOLS 03-06-2025
  • GCI 02-20-2025
  • Dividend Yield
  • EOLS N/A
  • GCI N/A
  • EPS Growth
  • EOLS N/A
  • GCI N/A
  • EPS
  • EOLS N/A
  • GCI N/A
  • Revenue
  • EOLS $248,326,000.00
  • GCI $2,557,445,000.00
  • Revenue This Year
  • EOLS $33.43
  • GCI N/A
  • Revenue Next Year
  • EOLS $32.44
  • GCI N/A
  • P/E Ratio
  • EOLS N/A
  • GCI N/A
  • Revenue Growth
  • EOLS 34.42
  • GCI N/A
  • 52 Week Low
  • EOLS $9.25
  • GCI $1.95
  • 52 Week High
  • EOLS $17.82
  • GCI $5.93
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 42.77
  • GCI 45.43
  • Support Level
  • EOLS $9.25
  • GCI $4.86
  • Resistance Level
  • EOLS $11.66
  • GCI $5.21
  • Average True Range (ATR)
  • EOLS 0.55
  • GCI 0.22
  • MACD
  • EOLS 0.06
  • GCI -0.00
  • Stochastic Oscillator
  • EOLS 52.28
  • GCI 28.57

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About GCI Gannett Co. Inc.

Gannett Co Inc is a digital newspaper company providing local media and marketing solutions in the U.S. The group operates in three segments, Domestic Gannett Media, Newsquest, and Digital Marketing Solutions. The majority of revenue is from the Domestic Gannett Media segment. The company's brands include USA TODAY and more than 250 daily newspapers as well as digital marketing services companies, including ReachLocal, WordStream, and others. The company produces more than 350 annual events, such as themed expos. The company also operates in the U.K. through the U.K. media company Newsquest, providing more than 150 local media brands.

Share on Social Networks: